@vanquish1xuc0
A study from Washington University in 2025 revealed that among 215,000 users of injectable weight-loss meds like Ozempic, Wegovy, and Mounjaro, there was a doubled chance of pancreatitis, a notable 11% spike in arthritis risk, and increased risks for low blood pressure and severe kidney problems.
0 reply
0 recast
0 reaction